Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Eli Lilly has been on a deal-making spree in recent years in a bid to increase products and sales in core franchises as older…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eli Lilly
Lilly’s pancreatic cancer treatment fails late-stage study
The trial evaluated Lilly's pegilodecakin plus Folfox, which is a combination of chemotherapy drugs, compared to Folfox alone in…
Lilly’s targeted RET drug shrinks tumours in lung cancer trial
Lilly’s drug, now called selpercatinib, is intended for patients with rare RET abnormalities, which occur in about 2 per cent of…
China expands drug bulk-buy programme, puts pressure on pharma firms
The programme, rolled out last year, saw 11 Chinese cities, including Beijing and Shanghai, band together behind a tender process…